132 related articles for article (PubMed ID: 30602061)
1. Risk stratification by somatic mutation burden in Ewing sarcoma.
Liu KX; Lamba N; Hwang WL; Niemierko A; DuBois SG; Haas-Kogan DA
Cancer; 2019 Apr; 125(8):1357-1364. PubMed ID: 30602061
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.
Tirode F; Surdez D; Ma X; Parker M; Le Deley MC; Bahrami A; Zhang Z; Lapouble E; Grossetête-Lalami S; Rusch M; Reynaud S; Rio-Frio T; Hedlund E; Wu G; Chen X; Pierron G; Oberlin O; Zaidi S; Lemmon G; Gupta P; Vadodaria B; Easton J; Gut M; Ding L; Mardis ER; Wilson RK; Shurtleff S; Laurence V; Michon J; Marec-Bérard P; Gut I; Downing J; Dyer M; Zhang J; Delattre O;
Cancer Discov; 2014 Nov; 4(11):1342-53. PubMed ID: 25223734
[TBL] [Abstract][Full Text] [Related]
3. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.
Lerman DM; Monument MJ; McIlvaine E; Liu XQ; Huang D; Monovich L; Beeler N; Gorlick RG; Marina NM; Womer RB; Bridge JA; Krailo MD; Randall RL; Lessnick SL;
Pediatr Blood Cancer; 2015 May; 62(5):759-65. PubMed ID: 25464386
[TBL] [Abstract][Full Text] [Related]
4. The prognostic signature of the somatic mutations in Ewing sarcoma: from a network view.
Zhang Y; Song J; Shi Q; Song X; Shen L; Zhou J; Shao J
Jpn J Clin Oncol; 2019 Jul; 49(7):604-613. PubMed ID: 30927420
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
[TBL] [Abstract][Full Text] [Related]
6. Ewing sarcoma: a tough road to clinically relevant biomarkers.
Shukla N
Pediatr Blood Cancer; 2015 May; 62(5):741-2. PubMed ID: 25586427
[No Abstract] [Full Text] [Related]
7. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma.
Casey DL; Pitter KL; Wexler LH; Slotkin EK; Gupta GP; Wolden SL
Br J Cancer; 2021 Aug; 125(4):576-581. PubMed ID: 34017087
[TBL] [Abstract][Full Text] [Related]
9. The genomic landscape of pediatric Ewing sarcoma.
Crompton BD; Stewart C; Taylor-Weiner A; Alexe G; Kurek KC; Calicchio ML; Kiezun A; Carter SL; Shukla SA; Mehta SS; Thorner AR; de Torres C; Lavarino C; Suñol M; McKenna A; Sivachenko A; Cibulskis K; Lawrence MS; Stojanov P; Rosenberg M; Ambrogio L; Auclair D; Seepo S; Blumenstiel B; DeFelice M; Imaz-Rosshandler I; Schwarz-Cruz Y Celis A; Rivera MN; Rodriguez-Galindo C; Fleming MD; Golub TR; Getz G; Mora J; Stegmaier K
Cancer Discov; 2014 Nov; 4(11):1326-41. PubMed ID: 25186949
[TBL] [Abstract][Full Text] [Related]
10. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.
van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE
J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828
[TBL] [Abstract][Full Text] [Related]
11. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.
Brohl AS; Solomon DA; Chang W; Wang J; Song Y; Sindiri S; Patidar R; Hurd L; Chen L; Shern JF; Liao H; Wen X; Gerard J; Kim JS; Lopez Guerrero JA; Machado I; Wai DH; Picci P; Triche T; Horvai AE; Miettinen M; Wei JS; Catchpool D; Llombart-Bosch A; Waldman T; Khan J
PLoS Genet; 2014 Jul; 10(7):e1004475. PubMed ID: 25010205
[TBL] [Abstract][Full Text] [Related]
12. Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.
Aryee DN; Niedan S; Ban J; Schwentner R; Muehlbacher K; Kauer M; Kofler R; Kovar H
Br J Cancer; 2013 Nov; 109(10):2696-704. PubMed ID: 24129240
[TBL] [Abstract][Full Text] [Related]
13. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of INK4A deletion in Ewing sarcoma.
Wei G; Antonescu CR; de Alava E; Leung D; Huvos AG; Meyers PA; Healey JH; Ladanyi M
Cancer; 2000 Aug; 89(4):793-9. PubMed ID: 10951342
[TBL] [Abstract][Full Text] [Related]
15. Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma.
Casey DL; Wexler LH; Pitter KL; Samstein RM; Slotkin EK; Wolden SL
Clin Cancer Res; 2020 Mar; 26(5):1135-1140. PubMed ID: 31699828
[TBL] [Abstract][Full Text] [Related]
16. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.
Belickova M; Vesela J; Jonasova A; Pejsova B; Votavova H; Merkerova MD; Zemanova Z; Brezinova J; Mikulenkova D; Lauermannova M; Valka J; Michalova K; Neuwirtova R; Cermak J
Oncotarget; 2016 Jun; 7(24):36266-36279. PubMed ID: 27167113
[TBL] [Abstract][Full Text] [Related]
18. PTPRD copy number variants and Ewing's sarcoma: Strengthening the association and therapeutic implications.
Saskin A; Seath K; Tihy F; Lemyre E; Davis J; Halal F; Armstrong L
Cancer Genet; 2019 Jun; 235-236():28-30. PubMed ID: 31072725
[TBL] [Abstract][Full Text] [Related]
19. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract][Full Text] [Related]
20. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
